Severe Hypoglycemia in Adults
暂无分享,去创建一个
[1] F. Service,et al. Diagnostic approach to adults with hypoglycemic disorders. , 1999, Endocrinology and metabolism clinics of North America.
[2] I. Deary,et al. Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. , 2000, Diabetes care.
[3] O. Søvik,et al. Dead-in-bed syndrome in young diabetic patients. , 1999, Diabetes care.
[4] R. Campbell. Glimepiride: Role of a New Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus , 1998, The Annals of pharmacotherapy.
[5] R. Landgraf,et al. A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas , 1999, European Journal of Clinical Pharmacology.
[6] C. Binder,et al. Symptomatic Hypoglycaemia in 411 Type 1 Diabetic Patients , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[7] S. Hart,et al. Causes, management and morbidity of acute hypoglycaemia in adults requiring hospital admission. , 1998, QJM : monthly journal of the Association of Physicians.
[8] R O Potts,et al. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. , 1999, Diabetes care.
[9] I J Deary,et al. Severe Hypoglycemia and Intelligence in Adult Patients With Insulin-Treated Diabetes , 1993, Diabetes.
[10] M. Palta,et al. Risk factors for frequent and severe hypoglycemia in type 1 diabetes. , 2001, Diabetes care.
[11] Douglas Borys,et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2004, The American journal of emergency medicine.
[12] W. Berger,et al. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[13] T. Litovitz,et al. 1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2000, The American journal of emergency medicine.
[14] T. Litovitz,et al. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1998, The American journal of emergency medicine.
[15] T. Merimee,et al. Stabilization of plasma glucose during fasting; Normal variations in two separate studies. , 1974, The New England journal of medicine.
[16] F. Service. Classification of hypoglycemic disorders. , 1999, Endocrinology and metabolism clinics of North America.
[17] B. Frier,et al. Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin , 2001, Diabetes/metabolism research and reviews.
[18] I. Cranston,et al. Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men , 1997, Diabetes Care.
[19] B P Kovatchev,et al. Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction. , 2000, Diabetes care.
[20] V. Marks,et al. Drug-induced hypoglycemia. , 1999, Endocrinology and metabolism clinics of North America.
[21] M. Burge,et al. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus. , 1998, JAMA.
[22] W. Ray,et al. Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas , 1998 .
[23] L. Jovanovic,et al. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. , 1999, JAMA.
[24] P. Cryer,et al. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. , 1988, The New England journal of medicine.
[25] B. Frier,et al. Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of Hypoglycemia , 1994, Diabetes Care.
[26] T. Nick,et al. The incidence of ethanol-induced hypoglycemia. , 1992, The American journal of emergency medicine.
[27] B. Clarke,et al. Comparison of Intravenous Glucagon and Dextrose in Treatment of Severe Hypoglycemia in an Accident and Emergency Department , 1987, Diabetes Care.
[28] M. Huic,et al. Adverse drug reactions resulting in hospital admission. , 1994, International journal of clinical pharmacology and therapeutics.
[29] G V Gill,et al. Unexplained Deaths of Type 1 Diabetic Patients , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[30] J. Levy,et al. U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease , 1995, Diabetes.
[31] J. Wahren,et al. Brain substrate utilisation during acute hypoglycaemia , 1999, Diabetologia.
[32] B. Frier,et al. Frequency and Morbidity of Severe Hypoglycaemia in Insulin‐treated Diabetic Patients , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[33] I. Deary,et al. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. , 1999, Diabetes care.
[34] H. Shamoon,et al. Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. , 1994, The American journal of medicine.
[35] B. Frier,et al. Frequency and Symptoms of Hypoglycaemia Experienced by Patients with Type 2 Diabetes Treated with Insulin , 1993, Diabetic medicine : a journal of the British Diabetic Association.
[36] T. Chalmers,et al. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes , 1993, The Lancet.
[37] F. Nuttall,et al. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial , 1995, Diabetes Care.
[38] K. Jungheim,et al. Risky delay of hypoglycemia detection by glucose monitoring at the arm. , 2001, Diabetes care.
[39] K. Ciechanowski,et al. Chlorpropamide toxicity with survival despite 27-day hypoglycemia. , 1999, Journal of toxicology. Clinical toxicology.
[40] I. Deary,et al. Hypoglycemia and Cognitive Function , 1993, Diabetes Care.
[41] B. Frier,et al. Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin , 1997, Diabetic Medicine.
[42] A. Maran,et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes , 1994, The Lancet.
[43] T. Noguchi,et al. Evaluation of Death from Hypoglycemia , 1988, The American journal of forensic medicine and pathology.
[44] M. Shichiri,et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. , 2000, Diabetes care.
[45] P Wach,et al. Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches , 1998, Diabetes Care.
[46] R. Rizza,et al. Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. , 1980, Metabolism: clinical and experimental.
[47] M. Stumvoll,et al. Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing -Adrenergic Sensitivity in Type 1 Diabetes , 2001, Annals of Internal Medicine.
[48] W. Tamborlane,et al. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. , 1999, Diabetes care.
[49] I. Mühlhauser,et al. Intensified insulin therapy and the risk of severe hypoglycaemia , 1997, Diabetologia.
[50] T. Koepsell,et al. Increasing incidence of serious hypoglycemia in insulin users. , 2002, Journal of clinical epidemiology.
[51] D. Schade,et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. , 1993, The Journal of clinical endocrinology and metabolism.
[52] T. Jones,et al. Decreased epinephrine responses to hypoglycemia during sleep. , 1998, The New England journal of medicine.
[53] D. Klonoff,et al. Hypoglycemia Following Inadvertent and Factitious Sulfonylurea Overdosages , 1995, Diabetes Care.
[54] A. Terzic,et al. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. , 1999, The Journal of clinical endocrinology and metabolism.
[55] C. D. Miller,et al. Hypoglycemia in patients with type 2 diabetes mellitus. , 2001, Archives of internal medicine.
[56] C. Airey,et al. Hypoglycaemia induced by exogenous insulin –‘human’ and animal insulin compared , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[57] M. Burge,et al. Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms. , 2001, The Journal of clinical endocrinology and metabolism.
[58] P. Boyle,et al. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[59] P. Cryer,et al. Reversibility of unawareness of hypoglycemia in patients with insulinomas. , 1993, The New England journal of medicine.
[60] Thomas Waldhoer,et al. Continuous subcutaneous insulin infusion in toddlers , 2003, European Journal of Pediatrics.